Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer.
Clin Cancer Res. 2023 Sep 1;29(17):3292-3300. doi: 10.1158/1078-0432.CCR-22-2585.
Clin Cancer Res. 2023.
PMID: 37339186
Clinical Trial.
Mitigating ipatasertib-induced glucose increase through dose and meal timing modifications.
Sutaria DS, Agarwal P, Huang KC, Miles DR, Rotmensch J, Hinton H, Gallo JD, Rasuo G, Sane RS.
Sutaria DS, et al. Among authors: gallo jd.
Clin Transl Sci. 2022 Dec;15(12):2989-2999. doi: 10.1111/cts.13420. Epub 2022 Nov 16.
Clin Transl Sci. 2022.
PMID: 36197694
Free PMC article.
Clinical Trial.
Item in Clipboard
Drug-Drug Interaction Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Ipatasertib in Combination with Darolutamide in Patients with Advanced Prostate Cancer.
Sutaria DS, Rasuo G, Harris A, Johnson R, Miles D, Gallo JD, Sane R.
Sutaria DS, et al. Among authors: gallo jd.
Pharmaceutics. 2022 Oct 1;14(10):2101. doi: 10.3390/pharmaceutics14102101.
Pharmaceutics. 2022.
PMID: 36297536
Free PMC article.
Item in Clipboard
Cite
Cite